Stock comparison
AMGEN INC is 6.8x more valuable than BIOGEN INC. by market capitalization ($249.37 B vs $36.75 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AMGN is larger
AMGEN INC is 6.8x more valuable than BIOGEN INC. by market capitalization ($249.37 B vs $36.75 B).
Market value leader
AMGN
AMGEN INC is 6.8x more valuable than BIOGEN INC. by market capitalization ($249.37 B vs $36.75 B).
Revenue leader
AMGN
AMGN: $36.75B vs BIIB: $9.89B.
Profit leader
AMGN
AMGN: $7.71B vs BIIB: $1.29B.
Margin leader
AMGN
AMGN: 21.0% vs BIIB: 13.1% net margin.
| Metric | AMGN | BIIB |
|---|---|---|
| Market cap | $249.37 B | $36.75 B |
| US-listed rank | #55 | #401 |
| Revenue (latest FY) | $36.75B | $9.89B |
| Net income (latest FY) | $7.71B | $1.29B |
| Net margin | 21.0% | 13.1% |
| P/E (trailing FY) | 32.3x | 28.4x |
| SEC filings | 1,011 | 2,692 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AMGEN INC is 6.8x more valuable than BIOGEN INC. by market capitalization ($249.37 B vs $36.75 B).
In their latest fiscal years, AMGEN INC reported $36.75B in revenue while BIOGEN INC. reported $9.89B.
Full pages: AMGEN INC and BIOGEN INC., or browse the full rankings.